ADaM Implementation Guide Status Update
|
|
- Georgia Carson
- 5 years ago
- Views:
Transcription
1 ADaM Implementation Guide Status Update John K. Troxell John Troxell Consulting LLC Bridgewater, NJ June 17, 2013
2 Current CDISC ADaM Documents 2009 Analysis Data Model (ADaM), Version 2.1 Analysis Data Model (ADaM) Implementation Guide, Version CDISC ADaM Validation Checks, Version Analysis Data Model (ADaM) Examples in Commonly Used Statistical Analysis Methods 2012 Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis, Version 1.0 The ADaM Basic Data Structure for Time-to-Event Analyses, Version 1.0 IG compliance update of CDISC-FDA Pilot I John Troxell - ADaM IG Status Update 2
3 ADaMIG to Date ADaM team started working on IG in 2006 Concentrated effort in 2009, published IG in Dec. Multiple work streams Published Validation Checks, Examples in Stat. Analysis, AE, TTE, compliance update of CDISC-FDA Pilot I Worked on metadata guide, general occurrences, integration, multivariate, PK, contributed to Define 2.0 Started to refocus on IG in 2H 2012 Learning from implementation experience Recently dedicating team meetings to IG, doubled frequency John Troxell - ADaM IG Status Update 3
4 ADaMIG Update Primarily driven by Cathy Barrows, GSK (retired) minor assistance from colead John Troxell Compiled list of suggestions/issues/deferred items Triaged: reject, do first, do later IG 1.1 draft for public comment targeted 2013* typos, error fixes clarifications (requires thought and discussion) some relatively easier issues and enhancements (but really none of them are easy and there is lots of deep thought and debate) IG 1.2 targeted 2014+* issues requiring deepest thought and extended debate more extensive document restructuring * Guaranteed by the ADaM Team or double your money back John Troxell - ADaM IG Status Update 4
5 Processing of Implementation Experience Clarify, clarify, clarify The scrutiny of the text by implementers is intense Impossible to be too precise Implementers misunderstandings Re-examine original thinking, clarify Objections to constraints Re-examine fundamental aspects of the model or data structure Can we ring-fence a proposed relaxation or exception without breaking the model and inviting chaos? Deep thought process and debate Additional features desired Debate, consider impacts, design Typos, errors Fix, considering backwards compatibility John Troxell - ADaM IG Status Update 5
6 Types of Clarification 1. We agree on what we meant and we need to express it more clearly. 2. We agreed on some language but now we realize we understood it differently. We need to agree on the meaning before we can clarify the text. 3. We realize we had not thought things through well enough to begin with. We need to clarify our thinking first. We may need to make some changes here and/or elsewhere in the standard, as well as clarify the text John Troxell - ADaM IG Status Update 6
7 Example of a Needed Clarification: 1:1 Map of AVAL:AVALC QS1 is a BDS parameter from a standard questionnaire. QSSTRESC contains the coded value of the answer. In SDTM In ADaM QSORRES QSSTRESC QSSTRESN AVISIT PARAMCD AVAL AVALC DTYPE VERY BAD 1 1 Week 8 QS1 1 VERY BAD BAD 2 2 Week 8 QS1 2 BAD GOOD 4 4 Week 8 QS1 4 GOOD We copy the answer from QSORRES into AVALC. We copy (or derive) the score and put it into AVAL. Within QS1, AVAL and AVALC map 1:1 as required by IG John Troxell - ADaM IG Status Update 7
8 Example of a Needed Clarification: 1:1 Map of AVAL:AVALC Per the SAP, we need to analyze the average Score for Week 8, so we derive a record for it. In SDTM In ADaM QSORRES QSSTRESC QSSTRESN AVISIT PARAMCD AVAL AVALC DTYPE VERY BAD 1 1 Week 8 QS1 1 VERY BAD BAD 2 2 Week 8 QS1 2 BAD GOOD 4 4 Week 8 QS1 4 GOOD Week 8 QS AVERAGE This looks good so far still 1:1 but what happens when we add more data.? John Troxell - ADaM IG Status Update 8
9 AVAL:AVALC In SDTM In ADaM QSORRES QSSTRESC QSSTRESN AVISIT PARAMCD AVAL AVALC DTYPE VERY BAD 1 1 Week 8 QS1 1 VERY BAD BAD 2 2 Week 8 QS1 2 BAD GOOD 4 4 Week 8 QS1 4 GOOD Week 8 QS AVERAGE OK 3 3 Week 8 QS1 3 OK VERY BAD 1 1 Week 8 QS1 1 VERY BAD BAD 2 2 Week 8 QS1 2 BAD Week 8 QS1 2.0 AVERAGE Now we don t have a 1:1 correspondence between AVAL and AVALC: AVAL=2.333 / AVALC=null AVAL=2.0 / AVALC=null This is a topic for clarification by the ADaM team John Troxell - ADaM IG Status Update 9
10 Example of a Needed Clarification: 1:1 Map of AVAL:AVALC Solution: clarify the scope of the 1:1 mapping requirement Clarify that AVAL and AVALC must be a one-to-one map within a parameter on the rows on which both AVAL and AVALC are populated We are making many scope clarifications in IG 1.1 A statement applies within a study? dataset? parameter? subject? Often this was unstated in IG John Troxell - ADaM IG Status Update 10
11 Common Misunderstandings and Impacts on Next Versions of IG Sometimes we observe people (including us) misunderstanding the IG or authors intent Misunderstandings point to places where the IG can be improved See Common Misunderstandings about ADaM Implementation, PharmaSUG N. Freimark, S. Kenny, J. Shostak, J. Troxell a snapshot of personal opinions of the authors not a complete list John Troxell - ADaM IG Status Update 11
12 Example of a Misunderstanding: Mistaking PARCATy as a Qualifier Parameter PARAM has no qualifiers Parameter Category PARCATy groups parameters into categories PARCATy does not subdivide or qualify PARAM ADaM Validation Check Error: There is more than one value of PARCATy for a given value of PARAMCD. Some have misunderstood PARCATy to be a qualifier of PARAM Misunderstanding often results from carrying over SDTM thinking ADaM SDTM PARCATy --CAT Basic Data Structure Findings Domain + AVAL/AVALC --STRESN/--STRESC John Troxell - ADaM IG Status Update 12
13 Example of a Misunderstanding: Mistaking PARCATy as a Qualifier Compliant but not scalable: PARAM AVAL Cumulative Dose of Drug A (mg) 1,234 Cumulative Dose of Drug B (mg) 8,765 Non-compliant but scalable: PARAM PARCAT1 AVAL Cumulative Dose (mg) Drug A 1,234 Cumulative Dose (mg) Drug B 8,765 For a company core controlled terminology for PARAM, it would be nice if we could have one parameter, not dozens. SO, wouldn t it be nice to misunderstand PARCATy? John Troxell - ADaM IG Status Update 13
14 Example of a Misunderstanding: Mistaking PARCATy as a Qualifier How should ADaM IG be modified? Clarify and emphasize that PARCATy is not a qualifier on PARAM and re-emphasize that PARAM has no qualifiers? Find a carefully ring-fenced way to permit limited qualifier functionality without permitting degeneration to SDTM TEST + qualifiers approach? Is this even possible? Deeper question than just PARCATy Need to address one way or the other John Troxell - ADaM IG Status Update 14
15 What you really wanted to hear about: Exactly what is changing? Not appropriate to publicize details until release for public comment Still evolving Some clues about 1.1 corrections of typos and minor errors clarifications (e.g. scopes, definitions, text) additional timing and other variables some features useful for oncology more Word tables minor restructuring of document 1.2 more profound issues addressed more restructuring coordinated model document update John Troxell - ADaM IG Status Update 15
16 Energy Around ADaM? Join Us! John Troxell - ADaM IG Status Update 16
Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1
PharmaSUG 2017 - Paper DS18 Clarifications About ADaM Implementation Provided in ADaMIG Version 1.1 John Troxell, Accenture ABSTRACT Since the publication of version 1.0 of the CDISC (Clinical Data Interchange
More informationPharmaSUG Paper DS06 Designing and Tuning ADaM Datasets. Songhui ZHU, K&L Consulting Services, Fort Washington, PA
PharmaSUG 2013 - Paper DS06 Designing and Tuning ADaM Datasets Songhui ZHU, K&L Consulting Services, Fort Washington, PA ABSTRACT The developers/authors of CDISC ADaM Model and ADaM IG made enormous effort
More informationYes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes!
1 Yes! The basic principles of ADaM are also best practice for our industry Yes! ADaM a standard with enforceable rules and recognized structures Yes! The ADaM documentation provides examples of many of
More informationDealing with changing versions of SDTM and Controlled Terminology (CT)
CDISC UK Network Breakout session Notes 07/06/16 Afternoon Session 1: Dealing with changing versions of SDTM and Controlled Terminology (CT) How do people manage this? Is this managed via a sponsor Standards
More informationWhat is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes What is the ADAM OTHER Class of Datasets, and When Should it be Used? John Troxell, Data Standards Consulting
More informationPharmaSUG Paper DS24
PharmaSUG 2017 - Paper DS24 ADQRS: Basic Principles for Building Questionnaire, Rating and Scale Datasets Nancy Brucken, inventiv Health, Ann Arbor, MI Karin LaPann, Shire, Lexington, MA ABSTRACT Questionnaires,
More informationIntroduction to ADaM and What s new in ADaM
Introduction to ADaM and What s new in ADaM Italian CDISC UN Day - Milan 27 th October 2017 Silvia Faini Principal Statistical Programmer CROS NT - Verona ADaM Purpose Why are standards needed in analysis
More informationPharmaSUG Paper DS-24. Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP
PharmaSUG 2018 - Paper DS-24 Family of PARAM***: PARAM, PARAMCD, PARAMN, PARCATy(N), PARAMTYP Kamlesh Patel, Rang Technologies Inc, New Jersey Jigar Patel, Rang Technologies Inc, New Jersey Dilip Patel,
More informationADaM Reviewer s Guide Interpretation and Implementation
Paper CD13 ADaM Reviewer s Guide Interpretation and Implementation Steve Griffiths, GlaxoSmithKline, Stockley Park, UK ABSTRACT Throughout the course of a study, teams will make a lot of decisions about
More informationTraceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA
ABSTRACT PharmaSUG 2013 - Paper PO13 Traceability in the ADaM Standard Ed Lombardi, SynteractHCR, Inc., Carlsbad, CA Traceability is one of the fundamentals of the ADaM Standard. However, there is not
More informationHow to write ADaM specifications like a ninja.
Poster PP06 How to write ADaM specifications like a ninja. Caroline Francis, Independent SAS & Standards Consultant, Torrevieja, Spain ABSTRACT To produce analysis datasets from CDISC Study Data Tabulation
More informationADaM IG v1.1 & ADaM OCCDS v1.0. Dr. Silke Hochstaedter
ADaM IG v1.1 & ADaM OCCDS v1.0 Dr. Silke Hochstaedter 1 Agenda What s new in Analysis Data Model Implementation Guide Version 1.1 The new ADaM Structure for Occurrence Data (OCCDS) Version 1.0 Q&A ADaM
More informationRiepilogo e Spazio Q&A
Riepilogo e Spazio Q&A CDISC Italian User Network Day 27 Ottobre 2017 Angelo Tinazzi (Cytel) - Silvia Faini (CROS NT) E3C members 2 Agenda ADaM key list Bad & Good ADaM...More... Spazio Q&A ADaM Key List
More informationBeyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity. John Brega Linda Collins PharmaStat LLC
Beyond OpenCDISC: Using Define.xml Metadata to Ensure End-to-End Submission Integrity John Brega Linda Collins PharmaStat LLC Topics Part 1: A Standard with Many Uses Status of the Define.xml Standard
More informationDCDISC Users Group. Nate Freimark Omnicare Clinical Research Presented on
DCDISC Users Group Nate Freimark Omnicare Clinical Research Presented on 2011-05-12 1 Disclaimer The opinions provided are solely those of the author and not those of the ADaM team or Omnicare Clinical
More informationADaM for Medical Devices: Extending the Current ADaM Structures
PharmaSUG 2018 - Paper MD-02 ADaM for Medical s: Extending the Current ADaM Structures Sandra Minjoe, PRA Health Sciences; Julia Yang, Medtronic PLC; Priya Gopal, TESARO, Inc. ABSTRACT The current ADaM
More informationIt s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0
PharmaSUG 2018 - Paper SS-15 It s All About Getting the Source and Codelist Implementation Right for ADaM Define.xml v2.0 ABSTRACT Supriya Davuluri, PPD, LLC, Morrisville, NC There are some obvious challenges
More informationXiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA
Building Traceability for End Points in Analysis Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen (Bob) Cui, Tathabbai Pakalapati, Qunming Dong Vertex Pharmaceuticals, Cambridge, MA 2010 Vertex
More informationAn Efficient Solution to Efficacy ADaM Design and Implementation
PharmaSUG 2017 - Paper AD05 An Efficient Solution to Efficacy ADaM Design and Implementation Chengxin Li, Pfizer Consumer Healthcare, Madison, NJ, USA Zhongwei Zhou, Pfizer Consumer Healthcare, Madison,
More informationInterpreting CDISC ADaM IG through Users Interpretation
Paper CD01 Interpreting CDISC ADaM IG through Users Interpretation Angelo Tinazzi, Cytel Inc., Geneva, Switzerland ABSTRACT It is now almost three years CDISC ADaM is an official standard the pharmaceutical
More informationDeriving Rows in CDISC ADaM BDS Datasets
ABSTRACT PharmaSUG 2017 Paper DS22 Deriving Rows in CDISC ADaM BDS Datasets Sandra Minjoe, Accenture Accelerated R&D Services The ADaM Basic Data Structure (BDS) can be used for many analysis needs, including
More informationUse of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission
PharmaSUG 2017 - Paper SS03 Use of Traceability Chains in Study Data and Metadata for Regulatory Electronic Submission ABSTRACT Tianshu Li, Celldex Therapeutics, Hampton, NJ Traceability is one of the
More informationLeveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO
PharmaSUG 2015 - Paper PO13 Leveraging ADaM Principles to Make Analysis Database and Table Programming More Efficient Andrew L Hulme, PPD, Kansas City, MO ABSTRACT The purpose of the CDISC Analysis Data
More informationNCI/CDISC or User Specified CT
NCI/CDISC or User Specified CT Q: When to specify CT? CT should be provided for every variable with a finite set of valid values (e.g., the variable AESEV in ADAE can have the values MILD, MODERATE or
More informationCreating an ADaM Data Set for Correlation Analyses
PharmaSUG 2018 - Paper DS-17 ABSTRACT Creating an ADaM Data Set for Correlation Analyses Chad Melson, Experis Clinical, Cincinnati, OH The purpose of a correlation analysis is to evaluate relationships
More informationHands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania
PharmaSUG 2013 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data Model (ADaM) Data Structure for Adverse Event Analysis
More informationAutomate Analysis Results Metadata in the Define-XML v2.0. Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc.
Automate Analysis Results Metadata in the Define-XML v2.0 Hong Qi, Majdoub Haloui, Larry Wu, Gregory T Golm Merck & Co., Inc., USA 1 Topics Introduction Analysis Results Metadata (ARM) Version 1.0 o o
More informationApplying ADaM Principles in Developing a Response Analysis Dataset
PharmaSUG2010 Paper CD03 Applying ADaM Principles in Developing a Response Analysis Dataset Mei Dey, Merck & Co., Inc Lisa Pyle, Merck & Co., Inc ABSTRACT The Clinical Data Interchange Standards Consortium
More informationIntroduction to ADaM standards
Introduction to ADaM standards Elke Sennewald, Director Biostatistics EU/AP, 06 March 2009 1 Outline ADaM Version 2.0 / 2.1 General Considerations ADaM draft Version 2.1 ADaMIG draft Version 1.0 ADaM Variables
More informationSandra Minjoe, Accenture Life Sciences John Brega, PharmaStat. PharmaSUG Single Day Event San Francisco Bay Area
Sandra Minjoe, Accenture Life Sciences John Brega, PharmaStat PharmaSUG Single Day Event San Francisco Bay Area 2015-02-10 What is the Computational Sciences Symposium? CSS originally formed to help FDA
More informationSome Considerations When Designing ADaM Datasets
Some Considerations When Designing ADaM Datasets Italian CDISC UN Day - Milan 27 th October 2017 Antonio Valenti Principal Statistical Programmer CROS NT - Verona Content Disclaimer All content included
More informationHands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania
PharmaSUG 2014 - Paper HT03 Hands-On ADaM ADAE Development Sandra Minjoe, Accenture Life Sciences, Wayne, Pennsylvania Kim Minkalis, Accenture Life Sciences, Wayne, Pennsylvania ABSTRACT The Analysis Data
More informationTraceability Look for the source of your analysis results
Traceability Look for the source of your analysis results Herman Ament, Cromsource CDISC UG Milan 21 October 2016 Contents Introduction, history and CDISC Traceability Examples Conclusion 2 / 24 Introduction,
More informationProgramming checks: Reviewing the overall quality of the deliverables without parallel programming
PharmaSUG 2016 Paper IB04 Programming checks: Reviewing the overall quality of the deliverables without parallel programming Shailendra Phadke, Baxalta US Inc., Cambridge MA Veronika Csom, Baxalta US Inc.,
More informationHarmonizing CDISC Data Standards across Companies: A Practical Overview with Examples
PharmaSUG 2017 - Paper DS06 Harmonizing CDISC Data Standards across Companies: A Practical Overview with Examples Keith Shusterman, Chiltern; Prathima Surabhi, AstraZeneca; Binoy Varghese, Medimmune ABSTRACT
More informationFrom SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI
PharmaSUG2011 - Paper HW05 From SAP to BDS: The Nuts and Bolts Nancy Brucken, i3 Statprobe, Ann Arbor, MI Paul Slagle, United BioSource Corp., Ann Arbor, MI ABSTRACT You've just read through the protocol,
More informationStudy Data Technical Conformance Guide (TCG)
Study Data Technical Conformance Guide (TCG) Webinar Series 2017 Center for Biologics Evaluation and Research (CBER) Center for Drug Evaluation and Research (CDER) The TCG TCG provides recommendations
More informationMaterial covered in the Dec 2014 FDA Binding Guidances
Accenture Accelerated R&D Services Rethink Reshape Restructure for better patient outcomes Sandra Minjoe Senior ADaM Consultant Preparing ADaM and Related Files for Submission Presentation Focus Material
More informationCDISC SDTM and ADaM Real World Issues
CDISC SDTM and ADaM Real World Issues Washington DC CDISC Data Standards User Group Meeting Sy Truong President MXI, Meta-Xceed, Inc. http://www.meta-x.com Agenda CDISC SDTM and ADaM Fundamentals CDISC
More informationADaM Implementation Guide Prepared by the CDISC ADaM Team
1 2 3 ADaM Implementation Guide Prepared by the CDISC ADaM Team 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Revision History Notes to Readers Date Version Summary of Changes May 30, 2008 1.0 Draft
More informationPharmaSUG2014 Paper DS09
PharmaSUG2014 Paper DS09 An ADaM Interim Dataset for Time-to-Event Analysis Needs Tom Santopoli, Accenture, Berwyn, PA Kim Minkalis, Accenture, Berwyn, PA Sandra Minjoe, Accenture, Berwyn, PA ABSTRACT
More informationImplementing CDISC Using SAS. Full book available for purchase here.
Implementing CDISC Using SAS. Full book available for purchase here. Contents About the Book... ix About the Authors... xv Chapter 1: Implementation Strategies... 1 The Case for Standards... 1 Which Models
More informationThe Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA
PharmaSUG 2017 - Paper DS23 The Benefits of Traceability Beyond Just From SDTM to ADaM in CDISC Standards Maggie Ci Jiang, Teva Pharmaceuticals, Great Valley, PA ABSTRACT Since FDA released the Analysis
More informationADaM Compliance Starts with ADaM Specifications
PharmaSUG 2017 - Paper DS16 ADaM Compliance Starts with ADaM Specifications Trevor Mankus, Kent Letourneau, PRA Health Sciences ABSTRACT As of December 17th, 2016, the FDA and PMDA require that all new
More informationTHE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC. PhUSE Bethan Thomas DATE PRESENTED BY
THE DATA DETECTIVE HINTS AND TIPS FOR INDEPENDENT PROGRAMMING QC DATE PhUSE 2016 PRESENTED BY Bethan Thomas What this presentation will cover And what this presentation will not cover What is a data detective?
More informationAvoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation
ABSTRACT Avoiding Sinkholes: Common Mistakes During ADaM Data Set Implementation Richann Watson, Experis, Batavia, OH Karl Miller, inventiv Health, Lincoln, NE The ADaM Implementation Guide was created
More informationAnalysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team
Analysis Data Model Implementation Guide Version 1.1 (Draft) Prepared by the CDISC Analysis Data Model Team Notes to Readers This Implementation Guide is version 1.1 and corresponds to Version 2.1 of the
More informationADaM and traceability: Chiesi experience
ADaM and traceability: Chiesi experience BIAS Seminar «Data handling and reporting in clinical trials with SAS» Glauco Cappellini 22-Feb-2013 Agenda Chiesi Model for Biometrics Regulatory Background ADaM:
More informationIntroduction to Define.xml
Introduction to Define.xml Bay Area CDISC Implementation Network 4 April 2008 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the concept and purpose of define.xml 2. Introduce the published
More informationAUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE
AUTOMATED CREATION OF SUBMISSION-READY ARTIFACTS SILAS MCKEE AGENDA 1. Motivation 2. Automation Overview 3. Architecture 4. Validating the System 5. Pilot Study Results 6. Future State Copyright 2012-2017
More informationOne-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc.
One-PROC-Away: The Essence of an Analysis Database Russell W. Helms, Ph.D. Rho, Inc. Chapel Hill, NC RHelms@RhoWorld.com www.rhoworld.com Presented to ASA/JSM: San Francisco, August 2003 One-PROC-Away
More informationMetadata and ADaM.
Metadata and ADaM 1 Disclaimer Any views or opinions presented in this presentation are solely those of the author and do not necessarily represent those of the company. 2 Agenda Introduction of ADaM Metadata
More informationDefine.xml 2.0: More Functional, More Challenging
Define.xml 2.0: More Functional, More Challenging Bay Area CDISC Implementation Network 24 July 2013 John Brega, PharmaStat LLC Presentation Objectives 1. Introduce the new features in Define.xml 2.0 with
More informationPharmaceuticals, Health Care, and Life Sciences. An Approach to CDISC SDTM Implementation for Clinical Trials Data
An Approach to CDISC SDTM Implementation for Clinical Trials Data William T. Chen, Merck Research Laboratories, Rahway, NJ Margaret M. Coughlin, Merck Research Laboratories, Rahway, NJ ABSTRACT The Clinical
More informationThe Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method
PharmaSUG 2015 - Paper AD01 The Implementation of Display Auto-Generation with Analysis Results Metadata Driven Method Chengxin Li, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA ABSTRACT
More informationStreamline SDTM Development and QC
Paper SI09 Streamline SDTM Development and QC Stephen Gormley, Amgen, United Kingdom ABSTRACT Amgen s Global Statistical Programming ( GSP ) function have one centralised team (The CDISC Consultancy and
More informationA Taste of SDTM in Real Time
A Taste of SDTM in Real Time Changhong Shi, Merck & Co., Inc., Rahway, NJ Beilei Xu, Merck & Co., Inc., Rahway, NJ ABSTRACT The Study Data Tabulation Model (SDTM) is a Clinical Data Interchange Standards
More informationFrom Implementing CDISC Using SAS. Full book available for purchase here. About This Book... xi About The Authors... xvii Acknowledgments...
From Implementing CDISC Using SAS. Full book available for purchase here. Contents About This Book... xi About The Authors... xvii Acknowledgments... xix Chapter 1: Implementation Strategies... 1 Why CDISC
More informationPharmaSUG Paper PO22
PharmaSUG 2015 - Paper PO22 Challenges in Developing ADSL with Baseline Data Hongyu Liu, Vertex Pharmaceuticals Incorporated, Boston, MA Hang Pang, Vertex Pharmaceuticals Incorporated, Boston, MA ABSTRACT
More informationAn Animated Guide: the logical cascade through the --Orres variable Russ Lavery, K&L consulting Services, Fort Washington, PA, U.S.A.
Paper PO12 An Animated Guide: the logical cascade through the --Orres variable Russ Lavery, K&L consulting Services, Fort Washington, PA, U.S.A. ABSTRACT This paper explores some of the complexity in the
More informationDIA 11234: CDER Data Standards Common Issues Document webinar questions
Q: What is the preferred data definition format for ADaM analysis data, define.xml or define.pdf? 1 ADaM Define File Q: The CRTDDS does not describe how to submit a define.xml for ADaM. Does CDER expect
More informationCDASH Standards and EDC CRF Library. Guang-liang Wang September 18, Q3 DCDISC Meeting
CDASH Standards and EDC CRF Library Guang-liang Wang September 18, 2014 2014 Q3 DCDISC Meeting 1 Disclaimer The content of this presentation does not represent the views of my employer or any of its affiliates.
More informationABSTRACT INTRODUCTION WHERE TO START? 1. DATA CHECK FOR CONSISTENCIES
Developing Integrated Summary of Safety Database using CDISC Standards Rajkumar Sharma, Genentech Inc., A member of the Roche Group, South San Francisco, CA ABSTRACT Most individual trials are not powered
More informationEdwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai, India
Paper CD15 PhUSE 2016 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences,
More informationDoctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development
PharmaSUG 2018 - Paper DS-15 Doctor's Prescription to Re-engineer Process of Pinnacle 21 Community Version Friendly ADaM Development Aakar Shah, Pfizer Inc; Tracy Sherman, Ephicacy Consulting Group, Inc.
More informationSAS Application to Automate a Comprehensive Review of DEFINE and All of its Components
PharmaSUG 2017 - Paper AD19 SAS Application to Automate a Comprehensive Review of DEFINE and All of its Components Walter Hufford, Vincent Guo, and Mijun Hu, Novartis Pharmaceuticals Corporation ABSTRACT
More informationSDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards
Paper CD02 SDTM Implementation Guide Clear as Mud: Strategies for Developing Consistent Company Standards Brian Mabe, UCB Biosciences, Raleigh, USA ABSTRACT Many pharmaceutical companies are now entrenched
More informationMapping and Terminology. English Speaking CDISC User Group Meeting on 13-Mar-08
Mapping and Terminology English Speaking CDISC User Group Meeting on 13-Mar-08 Statement of the Problem GSK has a large drug portfolio, therefore there are many drug project teams GSK has standards 8,200
More informationDataset-XML - A New CDISC Standard
Dataset-XML - A New CDISC Standard Lex Jansen Principal Software Developer @ SAS CDISC XML Technologies Team Single Day Event CDISC Tools and Optimization September 29, 2014, Cary, NC Agenda Dataset-XML
More informationCreating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS
Creating Define-XML v2 with the SAS Clinical Standards Toolkit 1.6 Lex Jansen, SAS Agenda Introduction to the SAS Clinical Standards Toolkit (CST) Define-XML History and Background What is Define-XML?
More informationManaging your metadata efficiently - a structured way to organise and frontload your analysis and submission data
Paper TS06 Managing your metadata efficiently - a structured way to organise and frontload your analysis and submission data Kirsten Walther Langendorf, Novo Nordisk A/S, Copenhagen, Denmark Mikkel Traun,
More informationIntroduction to User Stories. CSCI 5828: Foundations of Software Engineering Lecture 05 09/09/2014
Introduction to User Stories CSCI 5828: Foundations of Software Engineering Lecture 05 09/09/2014 1 Goals Present an introduction to the topic of user stories concepts and terminology benefits and limitations
More informationTraceability: Some Thoughts and Examples for ADaM Needs
PharmaSUG 2018 - Paper DS-01 Traceability: Some Thoughts and Examples for ADaM Needs Sandra Minjoe, PRA Health Sciences; Wayne Zhong, Accretion Softworks; Quan (Jenny) Zhou, Eli Lilly and Company; Kent
More informationTS04. Running OpenCDISC from SAS. Mark Crangle
TS04 Running OpenCDISC from SAS Mark Crangle Introduction The OpenCDISC validator is a tool used to check the compliance of datasets with CDISC standards Open-source Freely available and created by team
More informationA SERVICE ORGANIZATION S GUIDE SOC 1, 2, & 3 REPORTS
A SERVICE ORGANIZATION S GUIDE SOC 1, 2, & 3 REPORTS Introduction If you re a growing service organization, whether a technology provider, financial services corporation, healthcare company, or professional
More informationThe application of SDTM in a disease (oncology)-oriented organization
Paper CD01 The application of SDTM in a disease (oncology)-oriented organization Angelo Tinazzi, Alessandro Cattaneo, Enrica Paschetto, Sonia Colombini SENDO-Tech S.r.l., Milan, Italy ABSTRACT Applying
More informationStudy Data Reviewer s Guide Completion Guideline
Study Data Reviewer s Guide Completion Guideline 22-Feb-2013 Revision History Date Version Summary 02-Nov-2012 0.1 Draft 20-Nov-2012 0.2 Added Finalization Instructions 10-Jan-2013 0.3 Updated based on
More informationPharmaSUG Paper CD16
PharmaSUG2010 - Paper CD16 Checking for SDTM Compliance: The Need for Human Involvement Fred Wood and Adrienne Boyance Data Standards Consulting Octagon Research Solutions, Wayne, PA ABSTRACT An increasing
More informationPaper FC02. SDTM, Plus or Minus. Barry R. Cohen, Octagon Research Solutions, Wayne, PA
Paper FC02 SDTM, Plus or Minus Barry R. Cohen, Octagon Research Solutions, Wayne, PA ABSTRACT The CDISC Study Data Tabulation Model (SDTM) has become the industry standard for the regulatory submission
More informationPharmaSUG DS05
PharmaSUG 2013 - DS05 Building Traceability for End Points in Datasets Using SRCDOM, SRCVAR, and SRCSEQ Triplet Xiangchen Cui, Vertex Pharmaceuticals Incorporated Tathabbai Pakalapati, Cytel Inc. Qunming
More informationEnterprise Challenges of Test Data Size, Change, Complexity, Disparity, and Privacy
Size, Change, Complexity, Disparity, and Privacy For simple applications, representative test data can be relatively easy What if you are testing enterprise-scale applications? In enterprise data centers,
More informationManaging CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences
1 Managing CDISC version changes: how & when to implement? Presented by Lauren Shinaberry, Project Manager Business & Decision Life Sciences 2 Content Standards Technical Standards SDTM v1.1 SDTM IG v3.1.1
More informationCodelists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California
ABSTRACT PharmaSUG 2016 - Paper DS16 lists Here, Versions There, Controlled Terminology Everywhere Shelley Dunn, Regulus Therapeutics, San Diego, California Programming SDTM and ADaM data sets for a single
More informationPlanning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database
PharmaSUG 2017 - Paper DS13 Planning to Pool SDTM by Creating and Maintaining a Sponsor-Specific Controlled Terminology Database ABSTRACT Cori Kramer, Ragini Hari, Keith Shusterman, Chiltern When SDTM
More informationWorking with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA
PharmaSug2016- Paper HA03 Working with Composite Endpoints: Constructing Analysis Data Pushpa Saranadasa, Merck & Co., Inc., Upper Gwynedd, PA ABSTRACT A composite endpoint in a Randomized Clinical Trial
More informationThe Wonderful World of Define.xml.. Practical Uses Today. Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008
The Wonderful World of Define.xml.. Practical Uses Today Mark Wheeldon, CEO, Formedix DC User Group, Washington, 9 th December 2008 Agenda Introduction to Formedix What is Define.xml? Features and Benefits
More informationUpdates on CDISC Standards Validation
Updates on CDISC Standards Validation NJ CDISC User Group September 19, 2013 Topics CDISC standards validation initiative FDA update on SEND checks OpenCDISC v1.4.1 release OpenCDISC plans 2 CDISC validation
More informationComparison of FDA and PMDA Requirements for Electronic Submission of Study Data
Comparison of FDA and PMDA Requirements for Electronic Submission of Study Data Monika Kawohl Statistical Programming Accovion CDISC GSUG Meeting 15-Sep-2015 1 References FDA Website: Study Data Standards
More informationHow to handle different versions of SDTM & DEFINE generation in a Single Study?
Paper CD15 How to handle different versions of SDTM & DEFINE generation in a Single Study? Edwin Ponraj Thangarajan, PRA Health Sciences, Chennai, India Giri Balasubramanian, PRA Health Sciences, Chennai,
More informationLegacy to SDTM Conversion Workshop: Tools and Techniques
Legacy to SDTM Conversion Workshop: Tools and Techniques Mike Todd President Nth Analytics Legacy Data Old studies never die Legacy studies are often required for submissions or pharmacovigilence. Often
More informationPharmaSUG 2014 PO16. Category CDASH SDTM ADaM. Submission in standardized tabular form. Structure Flexible Rigid Flexible * No Yes Yes
ABSTRACT PharmaSUG 2014 PO16 Automation of ADAM set Creation with a Retrospective, Prospective and Pragmatic Process Karin LaPann, MSIS, PRA International, USA Terek Peterson, MBA, PRA International, USA
More informationLet s Create Standard Value Level Metadata
PhUSE US Connect 2019 Paper DS12 Let s Create Standard Value Level Metadata David Fielding, PRA Health Sciences, Brantford, Canada ABSTRACT Value Level Metadata is an important part of the Define-XML that
More informationCustomizing SAS Data Integration Studio to Generate CDISC Compliant SDTM 3.1 Domains
Paper AD17 Customizing SAS Data Integration Studio to Generate CDISC Compliant SDTM 3.1 Domains ABSTRACT Tatyana Kovtun, Bayer HealthCare Pharmaceuticals, Montville, NJ John Markle, Bayer HealthCare Pharmaceuticals,
More informationImproving Metadata Compliance and Assessing Quality Metrics with a Standards Library
PharmaSUG 2018 - Paper SS-12 Improving Metadata Compliance and Assessing Quality Metrics with a Standards Library Veena Nataraj, Erica Davis, Shire ABSTRACT Establishing internal Data Standards helps companies
More informationUnofficial Comment Form Project Modifications to CIP Standards Virtualization in the CIP Environment
Unofficial Comment Form Project 2016-02 Modifications to CIP Standards Virtualization in the CIP Environment Do not use this form for submitting comments. Use the electronic form to submit comments on
More informationNow let s take a look
1 2 3 4 Manage assets across the end to end life cycle of your studies This includes forms, datasets, terminologies, files, links and more, for example: - Studies may contain the protocol, a set of Forms,
More informationMain challenges for a SAS programmer stepping in SAS developer s shoes
Paper AD15 Main challenges for a SAS programmer stepping in SAS developer s shoes Sebastien Jolivet, Novartis Pharma AG, Basel, Switzerland ABSTRACT Whether you work for a large pharma or a local CRO,
More informationStandards Metadata Management (System)
Standards Metadata Management (System) Kevin Lee, MarkLogic COPYRIGHT 2015 MARKLOGIC CORPORATION. ALL RIGHTS RESERVED. Agenda Regulatory Requirement on Clinical Trial Standards(i.e., CDISC and ectd) Standards
More informationChallenges with the interpreta/on of CDISC - Who can we trust?
Challenges with the interpreta/on of CDISC - Who can we trust? Linda Palm Simonsson linda.simonsson@i- mind.se CD01 #PhUSE14 - London 2014-10- 13 Abstract Many smaller companies have none or very linle
More informationBusiness & Decision Life Sciences
Business & Decision Life Sciences Moving to Define.xml v2.0.0 for CDISC FSUG Anne-Sophie Bekx / 22 May 2014 Introduction Differences Impact Introduction History of Define.xml February 2005: CRT-DDS Final
More information